Zellgesundheit verstehen – gesund älter werden

Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell. 2018 Sep;174(6):1406-1423.e16. DOI: 10.1016/j.cell.2018.08.047

Suez J, Elinav E. The path towards microbiome-based metabolite treatment. Nat Microbiol. 2017 May 25;2(6):17075. DOI: 10.1038/nmicrobiol.2017.75

McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. European Heart Journal. 2024 Oct 7;45(38):3912–4018. DOI: 10.1093/eurheartj/ehae178

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal. 2020 Jan 1;41(1):111–88. DOI: 10.1093/eurheartj/ehz455

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008 Oct 9;359(15):1577–89. DOI: 10.1056/NEJMoa0806470

Rahimi K, Bidel Z, Nazarzadeh M, Copland E, Canoy D, Ramakrishnan R, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. The Lancet. 2021 May;397(10285):1625–36. DOI: 10.1016/S0140-6736(21)00590-0

Cholesterol Treatment Trialists’ (Ctt) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. The Lancet. 2012 Aug;380(9841):581–90. DOI: 10.1016/S0140-6736(12)60367-5

Bannister CA, Holden SE, Jenkins‐Jones S, Morgan CLl, Halcox JP, Schernthaner G, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls. Diabetes Obesity Metabolism. 2014 Nov;16(11):1165–73. DOI: 10.1111/dom.12354

Zhang Y, Peng H, Xin S, Mao J, Zhang J, Li H, et al. Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis on randomized-controlled trials. Syst Rev. 2025 Dec 30;15(1):35. DOI: 10.1186/s13643-025-03042-4

Rosano GMC, Aversa A, Vitale C, Fabbri A, Fini M, Spera G. Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk. European Urology. 2005 Feb;47(2):214–22. DOI: 10.1016/j.eururo.2004.10.002

Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009 Jul;460(7253):392–5. DOI: 10.1038/nature08221

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):311–22. DOI: 10.1056/NEJMoa1603827

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015 Nov 26;373(22):2117–28. DOI: 10.1056/NEJMoa1504720

Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, et al. Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly. Ann Intern Med. 2007 Jan 16;146(2):104–15. DOI: 10.7326/0003-4819-146-2-200701160-00005

Clayton PE, Banerjee I, Murray PG, Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol. 2011 Jan;7(1):11–24. DOI: 10.1038/nrendo.2010.171

Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, et al. Long-Term Anabolic-Androgenic Steroid Use Is Associated With Left Ventricular Dysfunction. Circ: Heart Failure. 2010 Jul;3(4):472–6. DOI: 10.1161/CIRCHEARTFAILURE.109.931063

Corona G, Rastrelli G, Giagulli VA, Sila A, Sforza A, Forti G, et al. Dehydroepiandrosterone Supplementation in Elderly Men: A Meta-Analysis Study of Placebo-Controlled Trials. The Journal of Clinical Endocrinology & Metabolism. 2013 Sep;98(9):3615–26. DOI: 10.1210/jc.2013-1358

Camon C, Garratt M, Correa SM. Exploring the effects of estrogen deficiency and aging on organismal homeostasis during menopause. Nat Aging. 2024 Dec 13;4(12):1731–44. DOI: 10.1038/s43587-024-00767-0

Lumsden MA, Dekkers OM, Faubion SS, Lindén Hirschberg A, Jayasena CN, Lambrinoudaki I, et al. European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause. European Journal of Endocrinology. 2025 Sep 30;193(4):G49–81. DOI: 10.1093/ejendo/lvaf206

Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. The Lancet Diabetes & Endocrinology. 2019 Oct;7(10):754–66. DOI: 10.1016/S2213-8587(19)30189-5